Products offered online or through unverified suppliers are likely to be unauthorised or counterfeit, and their use carries serious health risks
consider over-the-counter medicines for temporary relief Will it get better
As research continues Read More When GLP-1 Therapy Plateaus: What Clinicians Should Do Next May 13, 2026 Articles, Blood Glucose Control, Blood Glucose Control, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,492 views Everything seems to be working perfectly until it suddenly isnt
A substudy published in Nature Medicine enrolled 98 participants with MASLD for 48 weeks (Nature Medicine, 2024): At 12 mg, 93% of participants with fatty liver achieved normal liver fat levels
37 Progress gradually, focusing on one change at a time
The Phase 2 trial data confirms this: the 1mg dose group achieved only 8.7% weight loss at 48 weeks, indicating that low doses produce modest effects that accumulate slowly